| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,755 |
7,110 |
$225K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,250 |
3,084 |
$144K |
| 20610 |
|
1,600 |
1,352 |
$56K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
428 |
396 |
$21K |
| 73610 |
|
1,178 |
1,020 |
$19K |
| 73630 |
|
1,122 |
990 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
193 |
184 |
$14K |
| 11721 |
|
721 |
676 |
$8K |
| 73564 |
|
420 |
351 |
$8K |
| 73130 |
|
345 |
306 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
896 |
824 |
$6K |
| 73030 |
|
179 |
154 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
179 |
118 |
$2K |
| 99243 |
|
34 |
34 |
$2K |
| 73502 |
|
42 |
40 |
$936.46 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
141 |
119 |
$918.35 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
91 |
73 |
$673.55 |
| 11056 |
|
34 |
29 |
$369.32 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$280.70 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
63 |
54 |
$277.65 |
| 73010 |
|
14 |
12 |
$238.09 |
| 73562 |
|
15 |
13 |
$212.26 |
| 3044F |
|
313 |
247 |
$40.00 |
| 1160F |
|
184 |
165 |
$0.00 |
| 1159F |
|
146 |
133 |
$0.00 |
| 99024 |
|
1,261 |
1,053 |
$0.00 |
| 3008F |
|
6,528 |
5,819 |
$0.00 |
| 3066F |
|
532 |
493 |
$0.00 |
| 4010F |
|
101 |
95 |
$0.00 |